Skip to content

Geoffrey M. Parker, Chief Financial Officer at Allogene Therapeutics, sold ALLO on Oct 21, 2026

Data as of Oct 27

▼ SELL$48.7K36,342 shares at $1.34Geoffrey M. Parker Chief Financial OfficerALLO Allogene Therapeutics, Inc.
Watch ALLO
Traded
Oct 21, 2026
Disclosed
Oct 23, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Geoffrey M. Parker, Chief Financial Officer at Allogene Therapeutics, sold ALLO on Oct 21, 2026TRADEDDISCLOSED
ALLOSimilar stocks (XLV — its sector index fund), rebased to ALLO's price on the disclosure day
ALLO since disclosure
−1.6%
after the sale
Similar stocks (XLV) since disclosure
−0.1%
XLV — its sector index fund

Change in closing price from Oct 23, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ALLO →